Procurement of Medicines for Financial Year 2026-27

The Pakistan Institute of Medical Sciences (PIMS) Islamabad is inviting bids for the bulk purchase of medicines for the financial year 2026-27. This procurement is crucial for ensuring the continuous supply of essential medicines to the hospital and its patients. Interested bidders must be active on AGPR, DRAP, GST, and NTN registers to qualify for participation. Items being procured: - Medicines (specific list not provided in the notice) The procurement will be conducted by the PIMS Islamabad Secretariat (Purchase Section). The scope includes the supply of medicines in bulk quantities for the entire financial year 2026-27. This is a significant procurement requiring compliance with all regulatory and registration requirements. Bidders must submit their technical and financial bids in separate sealed envelopes as per the tender instructions. Eligibility criteria include valid registration with AGPR, DRAP, GST, and NTN. Bidders should also be registered with the relevant tax authorities and have experience in supplying medicines to government or large healthcare institutions. The tender process will follow the Public Procurement Regulatory Authority (PPRA) rules and will be advertised on the PPRA website and EPADS portal. The last date for submission of bids is 15 days after the publication date, by 12:00 noon. The technical bids will be opened on the same day at 12:30 pm in the presence of bidders or their representatives. The submission address is the Purchase Section, Secretariat, PIMS Islamabad. The tender will be processed under Section 33 of the Public Procurement Rules. A practical tip for bidders is to ensure that all required documents, including valid registration certificates and earnest money in the form of CDR, are complete and properly sealed. Late or incomplete submissions will be rejected. Careful attention to the bid submission deadline and compliance with all technical requirements will increase the chances of success in this competitive tender.